Research ArticleBasic Science Investigations
18F-EF5 PET Imaging as an Early Response Biomarker for the Hypoxia-Activated Prodrug SN30000 Combined with Radiation Treatment in a Non–Small Cell Lung Cancer Xenograft Model
Satish K. Chitneni, Gerald T. Bida, Hong Yuan, Gregory M. Palmer, Michael P. Hay, Thorsten Melcher, William R. Wilson, Michael R. Zalutsky and Mark W. Dewhirst
Journal of Nuclear Medicine August 2013, 54 (8) 1339-1346; DOI: https://doi.org/10.2967/jnumed.112.116293
Satish K. Chitneni
1Department of Radiology, Duke University Medical Center, Durham, North Carolina
Gerald T. Bida
1Department of Radiology, Duke University Medical Center, Durham, North Carolina
Hong Yuan
2Biomedical Research Imaging Center (BRIC), University of North Carolina, Chapel Hill, North Carolina
Gregory M. Palmer
3Department of Radiation Oncology, Duke University Medical Center, Durham, North Carolina
Michael P. Hay
4Auckland Cancer Society Research Centre, University of Auckland, Auckland, New Zealand; and
Thorsten Melcher
5Varian Medical Systems, Palo Alto, California
William R. Wilson
4Auckland Cancer Society Research Centre, University of Auckland, Auckland, New Zealand; and
Michael R. Zalutsky
1Department of Radiology, Duke University Medical Center, Durham, North Carolina
Mark W. Dewhirst
3Department of Radiation Oncology, Duke University Medical Center, Durham, North Carolina

Data supplements
Supplemental Data
Files in this Data Supplement:
In this issue
Journal of Nuclear Medicine
Vol. 54, Issue 8
August 1, 2013
18F-EF5 PET Imaging as an Early Response Biomarker for the Hypoxia-Activated Prodrug SN30000 Combined with Radiation Treatment in a Non–Small Cell Lung Cancer Xenograft Model
Satish K. Chitneni, Gerald T. Bida, Hong Yuan, Gregory M. Palmer, Michael P. Hay, Thorsten Melcher, William R. Wilson, Michael R. Zalutsky, Mark W. Dewhirst
Journal of Nuclear Medicine Aug 2013, 54 (8) 1339-1346; DOI: 10.2967/jnumed.112.116293
18F-EF5 PET Imaging as an Early Response Biomarker for the Hypoxia-Activated Prodrug SN30000 Combined with Radiation Treatment in a Non–Small Cell Lung Cancer Xenograft Model
Satish K. Chitneni, Gerald T. Bida, Hong Yuan, Gregory M. Palmer, Michael P. Hay, Thorsten Melcher, William R. Wilson, Michael R. Zalutsky, Mark W. Dewhirst
Journal of Nuclear Medicine Aug 2013, 54 (8) 1339-1346; DOI: 10.2967/jnumed.112.116293
Jump to section
Related Articles
Cited By...
- PET/CT in the Evaluation of Hypoxia for Radiotherapy Planning in Head and Neck Tumors: Systematic Literature Review
- Dual Targeting of Hypoxia and Homologous Recombination Repair Dysfunction in Triple-Negative Breast Cancer
- Comparison of the Hypoxia PET Tracer 18F-EF5 to Immunohistochemical Marker EF5 in 3 Different Human Tumor Xenograft Models